Mattawan, Mich. – MPI Research today announced it has named Susan L. Buckham, MS, as its new Vice President of Operations. In this role, Susan will be responsible for the strategic leadership and overall direction of operational activities for all functional areas involved with the coordination and execution of in vivo studies. In addition, she […]
Mattawan, Mich. – MPI Research announced it has completed the validation of its Instem submit™ software suite, allowing for the creation of consistent, accurate, and high quality datasets compliant with the Standard for Exchange of Nonclinical Data (SEND).
Initially powered by the FDA’s Critical Path Initiative to more efficiently bring medical breakthroughs to market, SEND supports […]
The primary objective of safety pharmacology studies is to identify potential adverse functional effects of a compound on the central nervous, respiratory, or cardiovascular systems.
Like many areas of drug development, safety pharmacology is a rapidly progressing industry segment. The technologies and tools available to conduct these studies are evolving and expanding regularly. A critical—and quickly […]
MPI Research Continues Expansion of Ophthalmology Capabilities with Addition of Veterinary Ophthalmologist
Mattawan, Mich. – MPI Research announced today it has welcomed Veterinary Ophthalmologist Ryan Boyd, DVM, MS, DACVO, to its growing team of ophthalmology experts.
“Dr. Boyd’s skills, experience and knowledge are welcome assets as we continue to expand this industry-leading specialization,” said Director of Ophthalmology Services Josh Bartoe, DVM, MS, DACVO. “Market demand for ophthalmology services […]
Andrew Augustine, MS, Senior Study Director, DMPK
One of the primary functions of the liver is to manufacture bile, which is necessary for the digestion of fat and elimination of drugs and their metabolites. Metabolism of drugs by the liver determines clearance and bioavailability. Rats are typically the first species used to characterize drug clearance, bioavailability, […]